New Scientist on MSN
Genetic trick to make mosquitoes malaria resistant passes key test
The rollout of a type of genetic technology called a gene drive for tackling malaria could be edging closer after a lab study ...
Arpita Bose and Zhecheng Zhang explore genetic tools in environmental microbes, citing applications in extracellular electron transfer ...
Karthik and her team aimed to use CRISPR as a way to identify and isolate a protein generated by the bacteria that cause Lyme ...
These science fiction masterpieces predicted aspects of the future with eerie uncanniness and left a lasting impression.
African Swine Fever Virus, ASFV, Viral Entry, Host Cell Invasion, CD163, Siglec-1, Macropinocytosis, Endosomal Escape, Immune Evasion, Signaling Pathways Share and Cite: Marcelino, K.B. and Fang, G.J.
Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI ...
OverviewThe global viral vector manufacturing market is projected to expand at a robust CAGR of approximately 20% over the forecast period, supported by multiple transformative forces reshaping the ...
Morning Overview on MSN
Programmable CRISPR cuts stem cell timing from months to weeks
Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...
The global synthetic biology market is poised for exponential growth, driven by a myriad of factors including increasing investments by government and private players, rising R&D funding and ...
Gene-edited goldenberries clear USDA review, moving closer to farms. Compact plants solve farming challenges for this ...
Morning Overview on MSN
Scientists zero in on a possible way to slow aging
For decades, the dream of slowing aging has hovered at the edge of science fiction, more marketing slogan than medical ...
The immunotherapies used to treat melanoma now include well-established drugs such as Keytruda (pembrolizumab) and Opdivo (nivolumab) and newer ones such as Amtagvi (lifileucel), which uses T cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results